Comprehensive Cancer Networks

How it works

Comparisons

Background

Evidence quality

Highlighted claims

• CCNs are contractual agreements between general hospitals and an academic hospital, structured around shared governance, tumour management groups, multidisciplinary team discussions, uniform cancer pathways, quality standards, and information exchange systems. — Comprehensive Cancer Networks in the Netherlands: how do they affect quality and costs of care for colon or pancreatic cancer? A retrospective cohort study
• By 2021, four CCNs were active in the Netherlands; regions without a formal CCN served as the study control group. — Comprehensive Cancer Networks in the Netherlands: how do they affect quality and costs of care for colon or pancreatic cancer? A retrospective cohort study
• No consistent evidence was found that CCNs reduce healthcare costs, lower mortality, rationalise referral patterns, or eliminate redundant diagnostics for colon or pancreatic cancer in the Netherlands. — Comprehensive Cancer Networks in the Netherlands: how do they affect quality and costs of care for colon or pancreatic cancer? A retrospective cohort study
• Broad implementation of CCNs without further research into the determinants of their success is not yet warranted. — Comprehensive Cancer Networks in the Netherlands: how do they affect quality and costs of care for colon or pancreatic cancer? A retrospective cohort study
• The theoretical mechanism behind CCNs holds that structured referrals, improved MTD-driven treatment decisions, and uniform pathways collectively reduce mortality and costs. — Comprehensive Cancer Networks in the Netherlands: how do they affect quality and costs of care for colon or pancreatic cancer? A retrospective cohort study
• Variation in outcomes across individual CCNs likely reflects underlying structural differences between networks rather than a coherent CCN-level effect. — Comprehensive Cancer Networks in the Netherlands: how do they affect quality and costs of care for colon or pancreatic cancer? A retrospective cohort study
• Where cost reductions were observed, the hypothesised causal pathway through referral concentration was not supported by parallel findings, casting doubt on whether savings operated through expected mechanisms. — Comprehensive Cancer Networks in the Netherlands: how do they affect quality and costs of care for colon or pancreatic cancer? A retrospective cohort study